|  |  |  |  | Allelic association | Dominant model | Recessive model | |||
---|---|---|---|---|---|---|---|---|---|---|
Study population | Genotype, n(%) | Risk allele, n(%) | P | OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | ||
rs3853839 | G/G | G/C | C/C | G | Â | Â | Â | Â | Â | Â |
SLE | 197(57.3) | 125 (36.3) | 22 (6.4) | 519 (75.4) | 0.017 | 1.36 (1.06 to 1.75) | 0.030 | 1.87 (1.05 to 3.31) | 0.072 | 1.34 (0.97 to 1.84) |
Controls | 137(50.0) | 106 (38.7) | 31 (11.3) | 380 (69.3) | Â | Â | Â | Â | Â | Â |
rs179019 | A/A | C/A | C/C | A | Â | Â | Â | Â | Â | Â |
SLE | 45 (13.1) | 131 (38.1) | 168 (48.8) | 221 (32.1) | 0.17 | 1.19 (0.93 to 1.52) | 0.77 | 1.05 (0.76 to 1.44) | 0.016b | 2.02 (1.15 to 3.54) |
Controls | 19 (6.9) | 118 (43.1) | 137 (50.0) | 156 (28.5) | Â | Â | Â | Â | Â | Â |
rs179010 | T/T | C/T | C/C | T | Â | Â | Â | Â | Â | Â |
SLE | 61 (17.7) | 156 (45.3) | 127 (36.9) | 278 (40.4) | 0.062 | 1.25 (0.99 to 1.57) | 0.36 | 1.16 (0.84 to 1.61) | 0.018 | 1.75 (1.10 to 2.80) |
Controls | 30 (10.9) | 133 (48.5) | 111 (40.5) | 193 (35.2) | Â | Â | Â | Â | Â | Â |